Prediction of fibril formation by early-stage amyloid peptide aggregation
Amyloid fibrils are found in systemic amyloidosis diseases such as Alzheimer’s disease, Parkinson’s disease, and type II diabetes. Currently, these diseases are diagnosed by observation of fibrils or plaques, which is an ineffective method for early diagnosis and treatment of disease. The goal of th...
Main Authors: | Jiaojiao Hu, Huiyong Sun, Haiping Hao, Qiuling Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-04-01
|
Series: | Journal of Pharmaceutical Analysis |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2095177919305817 |
Similar Items
-
Applications of Mass Spectrometry in the Onset of Amyloid Fibril Formation: Focus on the Analysis of Early-Stage Oligomers
by: Jiaojiao Hu, et al.
Published: (2020-05-01) -
Exploring the Early Stages of the Amyloid Aβ(1–42) Peptide Aggregation Process: An NMR Study
by: Angelo Santoro, et al.
Published: (2021-07-01) -
Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide.
by: Cottingham, MG, et al.
Published: (2002) -
Prediction of Peptide and Protein Propensity for Amyloid Formation.
by: Carlos Família, et al.
Published: (2015-01-01) -
Experimental characterization of disordered and ordered aggregates populated during the process of amyloid fibril formation.
by: Carulla, N, et al.
Published: (2009)